Search for: "Insys Therapeutics, Inc." Results 1 - 20 of 31
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jun 2022, 12:57 pm by Linda C. Severin
One defendant, Daniel Tondre, was a sales representative for Insys Therapeutics, Inc. [read post]
10 Jun 2021, 12:35 pm by Steve Lash
Howard Hoffberg said he received $66,600 from Insys Therapeutics Inc. in exchange for ... [read post]
27 Jan 2020, 5:26 pm by Ben Vernia
  In one matter, as part of a global resolution of criminal and civil claims, Insys Therapeutics paid $195 million to settle civil allegations that it paid kickbacks to induce physicians and nurse practitioners to prescribe Subsys for their patients. [read post]
24 Jan 2020, 10:24 am by luiza
Insys Therapeutics – In June 2019, opioid manufacturer Insys Therapeutics agreed to pay $225 million to resolve federal criminal and civil claims against it regarding the unlawful marketing of its drug Subsys, including the payment of kickbacks to physicians and their family members and friends. $195 million of the settlement will be paid to resolve False Claims Act allegations in five separate whistleblower lawsuits. [read post]
10 Jan 2020, 7:09 am by Tinker Ready
 Insys Therapeutics paid $195 million to settle civil allegations that it paid kickbacks to prescribers in “the form of sham speaker events, jobs for the prescribers’ relatives and friends, and lavish meals and entertainment. [read post]
9 Jan 2020, 11:43 am by luiza
Insys Therapeutics — Several whistleblowers shared in a whistleblower award of tens of millions of dollars from the $195 million Insys paid to resolve allegations it violated the False Claims Act by improperly marketing its Subsys drug and paying kickbacks to providers to induce their prescribing of the drug. [read post]
9 Jan 2020, 11:43 am by luiza
Insys Therapeutics — Several whistleblowers shared in a whistleblower award of tens of millions of dollars from the $195 million Insys paid to resolve allegations it violated the False Claims Act by improperly marketing its Subsys drug and paying kickbacks to providers to induce their prescribing of the drug. [read post]
27 Nov 2019, 11:06 am by Jordan Ross
A federal judge on Tuesday partially overturned convictions against high-level executives of Insys Therapeutics Inc. [read post]
19 Nov 2019, 7:44 am by Dan Bressler
Insys Exec Trial Fair Despite Alleged Weil Conflict, Judge Says” — “A convicted former Insys Therapeutics Inc. executive ‘got a fair trial’ despite Weil Gotshal & Manges LLP representing him during his criminal trial while guiding the company through its bankruptcy, a federal judge said following a fiery Thursday afternoon hearing over the alleged conflict. [read post]
21 Aug 2019, 7:46 am by Dan Bressler
“Judge Rules Exec Can Cite Alleged Weil Conflicts To Seek New Opioids Trial” — “The former national sales director of opioid medicine manufacturer Insys Therapeutics, seeking a new trial, has accused his ex-defense lawyers at Weil, Gotshal & Manges of hiding a conflict from him because their firm is also working on Insys’ bankruptcy. [read post]
6 Aug 2019, 3:02 am by Liz Dunshee
One company in the group is Insys Therapeutics Inc., said Prof. [read post]
25 Jul 2019, 7:44 am by Andrew Murray
On July 11, 2019, the Attorney General of Arizona announced the filing of a suit against former executives of the Chandler-based opioid manufacturer, Insys Therapeutics, Inc. [read post]
6 Jun 2019, 8:00 am by Jerri Lynn Ward, J.D.
The post Insys Therapeutics Inc. to Pay $225 Million to End Opioid Investigation appeared first on Garlo Ward, P.C.. [read post]
5 Mar 2019, 6:55 am by David Markus
So, Insys Therapeutics Inc. turned to a former exotic dancer, who once ran an escort service, to push sales of its highly addictive opioid painkiller.Insys’s former vice president of sales and marketing Alec Burlakoff told a Boston jury Friday that he hired Sunrise Lee as a regional sales manager after meeting her at a strip club in Florida, even though she had no relevant experience. [read post]
20 Feb 2019, 8:07 am by Renae Lloyd
Namaste Technologies (NASDAQOTH:NXTTF): down 75.2% Wayland Group: down 67.6% Insys Therapeutics(NASDAQ:INSY): down 63.6% Aphria(NYSE:APHA): down 61.3% Radient Technologies: down 60.7% Liberty Health Sciences: down 58% VIVO Cannabis: down 57.7% Emerald Health Therapeutics: down 51.5% Auxly Cannabis Group(NASDAQOTH:CBWTF): down 51.5% Medical Marijuana, Inc. [read post]
10 Jan 2019, 6:39 am by Lindsay Offutt
Former Insys Therapeutics Inc., CEO Michael Babich pleaded guilty on Wednesday to charges related to conspiracy and mail fraud stemming from the sale of a fentanyl nasal spray, Subsys. [read post]
20 Nov 2018, 5:23 am by Akira Tomlinson
” The amended lawsuit also add Insys Therapeutics, Inc., alleging that the company provided kickbacks to doctors to incentivize them to write prescriptions for opioids. [read post]
25 May 2018, 11:43 am by Brill Legal Group
The doctors allegedly accepted between $68,000 and $308,000 in bribes from Arizona-based Insys Therapeutics Inc. over a four-year period that started in August 2012. [read post]
18 May 2018, 3:08 pm by Green and Associates
On May 15, 2018, the United States intervened in five “whistleblower” lawsuits that have been consolidated in United States District Court in Los Angeles and accuse Insys Therapeutics, Inc. of paying illegal kickbacks and defrauding federal health programs in connection with the marketing of Subsys, an opioid painkiller manufactured and sold by the Arizona-based company. [read post]
18 May 2018, 3:08 pm by Green and Associates
On May 15, 2018, the United States intervened in five “whistleblower” lawsuits that have been consolidated in United States District Court in Los Angeles and accuse Insys Therapeutics, Inc. of paying illegal kickbacks and defrauding federal health programs in connection with the marketing of Subsys, an opioid painkiller manufactured and sold by the Arizona-based company. [read post]